Rx Compliance Activity By States Is Next Frontier, U.S. Attorney Loucks Says

State investigations of pharma manufacturers will present an increasing concern to the industry, Boston Assistant U.S. Attorney Michael Loucks told the Pharmaceutical Regulatory and Compliance Congress in Philadelphia Nov. 13